ACHV
ACHV
Positions held
Your positionsACHV isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-07 · Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
2026-10-06 · Achieve Life Sciences Announces Granting of New Hire Inducement Awards
2026-10-01 · Achieve Life Sciences Names Benjamin Halladay CFO
2026-10-01 · Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
2026-09-30 · Stifel Initiates Achieve Life Sciences at Buy With $18 Price Target
2026-09-03 · Achieve Life Sciences Announced Granting of New Hire Inducement Awards
2026-08-18 · ACHV: Looking Ahead to Resubmission
2026-08-13 · Morgan Stanley Initiates Achieve Life Sciences at Overweight, With $13 Price Target
2026-08-12 · Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit.
2026-08-11 · Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
Price (daily)
Full chart · RSI · MACD · patterns